Evidence map›Paper›PMID 35819995›Full record

ArticleChemistry & biodiversity2022

Cu-Catalyzed Chan-Evans-Lam Coupling Reactions of 2-Nitroimidazole with Aryl Boronic Acids: An Effort toward New Bioactive Agents against S. pneumoniae.

Selvam Raju, Patrick E Sheridan, Alanna K Hauer, Allyn E Garrett, Danielle E McConnell, Justin A Thornton, Sean L Stokes, Joseph P Emerson

Open access · greenAbstract read
In one paragraph

Article in Chemistry & biodiversity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Aminoquinoline-Based Tridentate (Molecules (Basel, Switzerland) · 2024
    Article
  4. Copper complexes for the chemoselectiveDalton transactions (Cambridge, England : 2003) · 2023
    Article
  5. Cu-NHC Complex for Chan-Evans-Lam Cross-Coupling Reactions ofEuropean journal of organic chemistry · 2023
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Selvam RajuDepartment of Chemistry, Mississippi State University, Mississippi, MS 39762, US.
Patrick E SheridanDepartment of Chemistry, Mississippi State University, Mississippi, MS 39762, US.
Alanna K HauerDepartment of Chemistry, Mississippi State University, Mississippi, MS 39762, US.
Allyn E GarrettDepartment of Chemistry, Mississippi State University, Mississippi, MS 39762, US.
Danielle E McConnellMississippi School for Math and Science, Columbus, MS 39701, US.
Justin A ThorntonDepartment of Biological Sciences, Mississippi State University, Mississippi, MS 39762, US.
Sean L StokesDepartment of Chemistry, Mississippi State University, Mississippi, MS 39762, US.
Joseph P EmersonDepartment of Chemistry, Mississippi State University, Mississippi, MS 39762, US.ORCID http://orcid.org/0000-0002-7556-1393
Mississippi State University · USMississippi School for Mathematics and Science · US

Funding

Zinc dependent conformational changes in AdcR and their impact on DNA bindingP20GM103646 · NIGMS · MISSISSIPPI STATE UNIVERSITY · PI THIBAUDEAU, GISELLE · 2013 to 2022
$21.1M
NIGMS NIH HHS P20 GM103646
6 · The paper itself

Abstract

The coupling of phenylboronic acids with poorly-activated imidazoles is studied as a model system to explore the use of copper-catalyzed Chan-Evans-Lam (CEL) coupling for targeted C-N bond forming reactions. Optimized CEL reaction conditions are reported for four phenanthroline-based ligand systems, where the ligand 4,5-diazafluoren-9-one (dafo, L2) with 1 molar equivalent of potassium carbonate yielded the highest reactivity. The substrate 2-nitroimidazole (also known as azomycin) has documented antimicrobial activity against a range of microbes. Here N-arylation of 2-nitroimidazole with a range of aryl boronic acids has been successfully developed by copper(II)-catalyzed CEL reactions. Azomycin and a range of newly arylated azomycin derivatives were screened against S. pneumoniae, where 1-(4-(benzyloxy)phenyl)-2-nitro-1H-imidazole (3d) was demonstrated to have a minimal inhibition concentration value of 3.3 μg/mL.

Indexed as

CopperNitroimidazolesBoronic AcidsCatalysisLigandsazomycinBoronic AcidsCopperLigandsNitroimidazolesazomycinC−N bond forming reactionscopper(II)nitroimidazoleS. pneumoniae

Identifiers

PMID35819995
PMCPMC10184775
OpenAlexW4285077437

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.